APA (7th ed.) Citation

Michelongona, A., Toutouzas, K., Synetos, A., Drakopoulou, M., Benetos, G., Zagouri, F., . . . Stefanadis, C. (2014). EFFICACY OF THE ANGIOGENESIS INHIBITOR OF BEVACIZUMAB ON THE ARTERIAL SCLEROSIS OF CANCER PATIENTS. Journal of the American College of Cardiology (JACC), 63, A2121. https://doi.org/10.1016/S0735-1097(14)62124-0

Chicago Style (17th ed.) Citation

Michelongona, Archontoula, et al. "EFFICACY OF THE ANGIOGENESIS INHIBITOR OF BEVACIZUMAB ON THE ARTERIAL SCLEROSIS OF CANCER PATIENTS." Journal of the American College of Cardiology (JACC) 63 (2014): A2121. https://doi.org/10.1016/S0735-1097(14)62124-0.

MLA (9th ed.) Citation

Michelongona, Archontoula, et al. "EFFICACY OF THE ANGIOGENESIS INHIBITOR OF BEVACIZUMAB ON THE ARTERIAL SCLEROSIS OF CANCER PATIENTS." Journal of the American College of Cardiology (JACC), vol. 63, 2014, p. A2121, https://doi.org/10.1016/S0735-1097(14)62124-0.